ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ROQ Roquefort Therapeutics Plc

5.25
0.00 (0.00%)
Last Updated: 03:00:05
Delayed by 15 minutes

Roquefort Therapeutics Financial Summary

The current ROQ market cap is 6.78M. The company's latest EPS is GBP -0.0135 and P/E is -3.89.

Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Revenue 1,0000200k
Operating Income -916k-1.63M-1.93M
Net Income -916k-1.62M-1.75M
Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Assets 4.56M7.77M6.09M
Total Liabilities 477k561k589k
Total Equity 4.08M7.21M5.5M

Cash Flow

Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Operating -516k-1.58M-1.73M
Investing -606k-103k-53k
Financing 2.02M3.1M N/A
Market Cap 6.78M
Price to Earnings Ratio -3.89
Price to Sales Ratio 35
Price to Cash Ratio 12.5
Price to Book Ratio 1.23
Dividend Yield -

Share Statistics

Shares Outstanding 129.15M
Average Volume (1 week) 894.03k
Average Volume (1 Month) 249.18k
52 Week Change -22.22%
52 Week High 9.25
52 Week Low 4.00
Spread (Intraday) 0.5 (9.09%)

Company Info

Company Name Roquefort Therapeutics Plc
Address 85 great portland street
london W1W 7LT
Website https://www.roquefortplc.com
Industry cmp integrated sys design (7373)